1. Home
  2. OII vs IOVA Comparison

OII vs IOVA Comparison

Compare OII & IOVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OII
  • IOVA
  • Stock Information
  • Founded
  • OII 1964
  • IOVA 2007
  • Country
  • OII United States
  • IOVA United States
  • Employees
  • OII N/A
  • IOVA N/A
  • Industry
  • OII Oilfield Services/Equipment
  • IOVA Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • OII Energy
  • IOVA Health Care
  • Exchange
  • OII Nasdaq
  • IOVA Nasdaq
  • Market Cap
  • OII 2.7B
  • IOVA 2.6B
  • IPO Year
  • OII N/A
  • IOVA N/A
  • Fundamental
  • Price
  • OII $22.53
  • IOVA $5.78
  • Analyst Decision
  • OII Hold
  • IOVA Strong Buy
  • Analyst Count
  • OII 5
  • IOVA 9
  • Target Price
  • OII $28.20
  • IOVA $23.06
  • AVG Volume (30 Days)
  • OII 688.2K
  • IOVA 7.5M
  • Earning Date
  • OII 02-19-2025
  • IOVA 02-27-2025
  • Dividend Yield
  • OII N/A
  • IOVA N/A
  • EPS Growth
  • OII 51.58
  • IOVA N/A
  • EPS
  • OII 1.44
  • IOVA N/A
  • Revenue
  • OII $2,661,161,000.00
  • IOVA $90,858,000.00
  • Revenue This Year
  • OII $9.79
  • IOVA $13,803.28
  • Revenue Next Year
  • OII $6.95
  • IOVA $167.55
  • P/E Ratio
  • OII $15.65
  • IOVA N/A
  • Revenue Growth
  • OII 9.75
  • IOVA 12751.20
  • 52 Week Low
  • OII $19.68
  • IOVA $5.05
  • 52 Week High
  • OII $30.98
  • IOVA $18.33
  • Technical
  • Relative Strength Index (RSI)
  • OII 30.03
  • IOVA 44.96
  • Support Level
  • OII $24.69
  • IOVA $5.44
  • Resistance Level
  • OII $26.11
  • IOVA $5.80
  • Average True Range (ATR)
  • OII 0.89
  • IOVA 0.32
  • MACD
  • OII -0.16
  • IOVA 0.08
  • Stochastic Oscillator
  • OII 4.79
  • IOVA 65.77

About OII Oceaneering International Inc.

Oceaneering International Inc is a global provider of engineered services and products robotic solutions to the offshore energy, defense, aerospace, manufacturing and entertainment industries. Most of Oceaneering's products are produced for the offshore oil and gas market. It had a 2020 segment realignment to promote synergies and cost efficiency. The five segments are subsea robotics; manufactured products; offshore projects group; integrity management and digital solutions; and aerospace and defense technologies. Within the segments are two businesses - services and products provided primarily to the oil and gas industry. The firm is also involved in the offshore renewables and mobility solutions industries.

About IOVA Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.

Share on Social Networks: